Group One Trading’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.3K Buy
+29,700
New +$16.9K ﹤0.01% 5795
2024
Q4
– Sell
-500
Closed -$1.91K – 7794
2024
Q3
$1.91K Sell
500
-13,200
-96% -$44K ﹤0.01% 6157
2024
Q2
$40.1K Sell
13,700
-9,600
-41% -$30.7K ﹤0.01% 4685
2024
Q1
$92.3K Sell
23,300
-38,500
-62% -$198K ﹤0.01% 4221
2023
Q4
$307K Buy
61,800
+52,100
+537% +$259K ﹤0.01% 3486
2023
Q3
$49K Sell
9,700
-11,900
-55% -$65.2K ﹤0.01% 5114
2023
Q2
$109K Buy
21,600
+19,600
+980% +$128K ﹤0.01% 4528
2023
Q1
$12.3K Sell
2,000
-500
-20% -$4.09K ﹤0.01% 5822
2022
Q4
$33K Buy
+2,500
New +$17.6K ﹤0.01% 5278
2021
Q3
– Sell
-400
Closed -$5K – 8632
2021
Q2
$5K Buy
+400
New +$3.12K ﹤0.01% 7772

Other funds holding PDSB

Group One Trading's PDSB Position: Q3 2026 in Review

Group One Trading increased its PDS Biotechnology (PDSB) stake by 2,960% in Q3 2026, buying an estimated $60K and bringing the position to 109,147 shares worth $81.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4870.

Group One Trading first reported a position in PDSB in Q1 2018 and has held it in 29 quarters since. The position peaked at $264K in Q4 2023. 60 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

  • Group One Trading held 109,147 shares of PDS Biotechnology worth $81.9K as of Q3 2026.
  • Group One Trading bought 105,580 PDS Biotechnology shares in Q3 2026, an estimated $60K.
  • PDS Biotechnology made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #4870 holding.
  • Group One Trading first reported a position in PDS Biotechnology in Q1 2018 and has held it in 29 quarters since.
  • Group One Trading's PDS Biotechnology position peaked at $264K in Q4 2023.
  • 60 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.